Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 2/2011

01-06-2011 | Nephrology – Original Paper

Diabetics on hemodialysis in El-Minia Governorate, Upper Egypt: five-year study

Authors: Osama El-Minshawy, Emad G. Kamel

Published in: International Urology and Nephrology | Issue 2/2011

Login to get access

Abstract

Introduction

The number of patients with end-stage renal disease (ESRD) due to diabetic nephropathy (DN) is increasing worldwide. In many countries, diabetes mellitus has become the most frequent cause of ESRD. The goal of this work is to critically evaluate the prevalence of DN among chronic regular hemodialysis (HD) patients in El-Minia Governorate, to evaluate changes over the course of 5 years, and to compare data of El-Minia Governorate with data from the United States and other countries, in an attempt to detect factors that might explain causes of the differences.

Material and methods

Data of patients on HD enrolled in the annual registry of the causes of ESRD in El-Minia Governorate were evaluated during the period from 2004 to 2008 for prevalence of DN. ESRD related to diabetes was defined as people who were initiated on chronic regular HD with diabetes mellitus as the cause of ESRD.

Results

The prevalence of DN among HD patients increased from 5% in 2004 to 16% in 2008. The mean age was significantly higher than that of ESRD patients on HD due to other etiologies. Furthermore, DN was more prevalent in urban areas than rural areas.

Conclusion

Diabetic nephropathy among HD patients in El-Minia Governorate is increasing but is less prevalent than in the United States and other Western countries, probably because of a higher incidence of other causes of ESRD in El-Minia governorate, or because of premature death of diabetic patients. Therefore, meticulous management of diabetic patients is mandatory.
Literature
1.
Panzetta G, Basile C, Santoro A et al (2008) Diabetics on dialysis in Italy: a nationwide epidemiological study. Nephrol Dial Transpl 23:3988–3995CrossRef
2.
Woredekal Y (2008) Early detection and treatment of diabetic nephropathy. Pediatr Endocrinol Rev 5:999–1004PubMed
3.
Kalantar-Zadeh K, Derose SF, Nicholas S et al (2009) Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus. J Ren Nutr 19:33–37PubMedCrossRef
4.
Earle KA, Porter KK, Ostberg J et al (2001) Variation in the progression of diabetic nephropathy according to racial origin. Nephrol Dial Transplant 16:286–290PubMedCrossRef
5.
Halimi S, Zmirou D, Benhamou PY et al (1999) Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas French territories. A second national survey six years apart. (UREMIDIAB 2 study). Diabetes Metab 25:507–512PubMed
6.
Hollenberg NK (2001) Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. Curr Hypertens Rep 3:177PubMedCrossRef
7.
Afifi A, Karim MA (1999) Renal replacement therapy in Egypt: first annual report of the Egyptian Society of Nephrology. East Mediterr Health J 5:1023–1029PubMed
8.
Afifi A, El Setouhy M, El Sharkawy M et al (2004) Diabetic nephropathy as a cause of end-stage renal disease in Egypt: a six-year study. East Mediterr Heath J 10:1–7
9.
El-Minshawy O, El-Sharqawy M, Ewais E (2002) End stage renal disease in El-Minia Governorate (Central Egypt): an epidemiological study. J Egypt Soc Nephrol 4:34–41
10.
El-Minshawy O, Kamel EG (2006) Renal replacement therapy and increased risk of cardiovascular disease in El-Minia Governorate, Upper Egypt. Egypt J Hosp Med 22:20–38
11.
Lim YN, Lim TO, Lee DG et al (2008) Report of the Malaysian dialysis registry of the National Renal Registry, Malaysia. Med J Malaya 63:5–8PubMed
12.
Nakai S, Masakane I, Akiba T (2008) Overview of regular dialysis treatment in Japan as of 31 December 2006. Ther Apher Dial 126:428–456CrossRef
13.
US Renal Data System (2007) USRDS 2006 Annual Data Report: Atlas of End Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
14.
Agarwal SK, Srivastava RK (2009) Chronic kidney disease in India: challenges and solutions. Nephron Clin Pract 111:c197–c203PubMedCrossRef
15.
Pérez-García R, Martín-Malo A, Fort J (2009) ANSWER study: baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER—a multicentre, prospective, observational cohort study. Nephrol Dial Transplant 24:578–588PubMedCrossRef
16.
Barsoum R (2003) End-stage renal disease in North Africa. Kidney Int Suppl 83:111–114CrossRef
17.
Moukeh G, Yacoub R, Fahdi F (2009) Epidemiology of hemodialysis patients in Aleppo city. Saudi J Kidney Dis Transpl 20:140–146PubMed
18.
Khanfri N, Medkouri G, Aghai R (2005) Diabetic nephropathy in hemodialysis patients in Casablanca. Saudi J Kidney Dis Transpl 16:89–92PubMed
19.
Alebiosu CO, Ayodele OE (2006) The increasing prevalence of diabetic nephropathy as a cause of end stage renal disease in Nigeria. Trop Doct 36:218–219PubMedCrossRef
20.
Bergrem H, Leivestad T (2001) Diabetic nephropathy and end-stage renal failure: the Norwegian story. Adv Ren Replace Ther 8:4–12PubMedCrossRef
21.
Arab M (1992) Diabetes mellitus in Egypt. World Health Stat Q 45:334–337PubMed
22.
Harman WH (1995) Diabetes mellitus in Egypt: risk factors and prevalence. Diabet Med 12:1126–1131CrossRef
23.
King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431PubMedCrossRef
24.
Speakman JR (2008) Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective the ‘drifty gene’ hypothesis. Int J Obes (Lond) 32(11):1611–1617CrossRef
25.
Nair L, Nair MK, Chacko DS (2009) Markers of fetal onset adult diseases. Indian Pediatr 46(Suppl):s48–s54PubMed
26.
Bhopal RS, Rafnsson SB (2009) Could mitochondrial efficiency explain the susceptibility to adiposity, metabolic syndrome, diabetes and cardiovascular diseases in South Asian populations? Int J Epidemiol 38(4):1072–1081PubMedCrossRef
27.
Stack AG, Bloembergen WE (2001) Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. J Am Soc Nephrol 12:1516–1523PubMed
28.
Eggers PW, Gohdes D, Pugh J (1999) Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney Int 56:1524–1533PubMedCrossRef
29.
Schomig M, Ritz E, Standl E (2000) The diabetic foot in the dialyzed patient. J Am Soc Nephrol 11:1153–1159PubMed
30.
Herzog CA, Ma JZ, Collins AJ (1998) Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339:799–805PubMedCrossRef
Metadata
Title
Diabetics on hemodialysis in El-Minia Governorate, Upper Egypt: five-year study
Authors
Osama El-Minshawy
Emad G. Kamel
Publication date
01-06-2011
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 2/2011
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-010-9713-z

Other articles of this Issue 2/2011

International Urology and Nephrology 2/2011 Go to the issue

Urology - Original Paper

The effect of prostate cancer screening on stage IV disease in America

Urology – Original Paper

Using urine microscopy and cytology for early detection of bladder cancer in male patients with lower urinary tract symptoms

Urology – Original Paper

The practice of the first check cystoscopy following radiotherapy for the treatment of muscle-invasive (T3N0M0) bladder cancer: a UK national survey

Nephrology – Original Paper

Hypovitaminosis D and insulin resistance in peritoneal dialysis patients

Urology – Original Paper

Sexual dysfunction in type III chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS) observed in Turkish patients

Nephrology – Original Paper

Endothelial nitric oxide synthase gene intron 4 polymorphism predicts new onset diabetes mellitus after transplantation in kidney allograft recipients treated with cyclosporin A
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits